Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1127 POSTS

Exclusive articles:

SKN | Peace Acquisition Corp Units: SPAC Return Tests Fragile Investor Appetite in a Tight Capital Market

Peace Acquisition Corp is moving toward a public listing as the SPAC market continues to struggle for relevance in a post-boom environment marked by...

SKN | Federal Agricultural Mortgage Corporation: Government-Backed Agrifinance Model Draws Attention in Equity Markets

Federal Agricultural Mortgage Corporation is moving toward a public market transaction involving its common stock, targeting approximately $8 million US in IPO-related proceeds as...

SKN | D-Wave Quantum Surges as Investor Optimism Around Commercial Quantum Computing Accelerates

D-Wave Quantum Inc. shares surged more than 30 percent as investor enthusiasm surrounding the commercial quantum computing industry continued accelerating. The strong rally reflects growing...

SKN | Applied Digital Surges After Hyperscaler AI Deal Fuels Revenue Expansion Outlook

Applied Digital Shares Jump Following Major AI Infrastructure Agreement Applied Digital Corporation shares surged more than 20 percent after the company announced a significant long-term...

SKN | US IPO Pricings Expand as Weak Debut Performance Reinforces Selective Risk Appetite

Key Points AMASS Brands Inc. (AMSS) weak aftermarket trading signals weakening demand for newly priced consumer-focused IPOs despite continued US issuance activity. Lincoln International...

Breaking

SKN | IPO Markets Diverge as Lycia Therapeutics Surges, European Shipping Finance Advances and Jio Platforms Draws Indian Demand

Key Points: Lycia Therapeutics raised approximately $317.5 million in...

SKN | BHAV Acquisition II Cuts Proposed IPO Size by 33% to $100 Million

BHAV Acquisition II, a special purpose acquisition company (SPAC)...

SKN | Lycia Therapeutics Raises $318 Million in Upsized IPO at Top of Range

Lycia Therapeutics, a clinical-stage biotechnology company developing protein-degrading therapies...
spot_imgspot_img